Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$519.87
Market cap
$7.79B
P/E Ratio
25.98
Dividend/share
$1.8
EPS
$20.01
Enterprise value
$7.7B
Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of
Highlights
Chemed's quick ratio has increased by 43% YoY and by 5% from the previous quarter
The net income has grown by 23% year-on-year
The debt is up by 8% year-on-year
Key stats
What are the main financial stats of CHE
Market
Valuations
Earnings
Shares outstanding
14.98M
Market cap
$7.79B
Enterprise value
$7.7B
Price to earnings (P/E)
25.98
Price to book (P/B)
6.33
Price to sales (P/S)
3.29
EV/EBIT
19.41
EV/EBITDA
16.76
EV/Sales
3.24
Revenue
$2.38B
Gross profit
$847.8M
Net income
$301.73M
EBIT
$396.56M
EBITDA
$459.32M
Free cash flow
$315.79M
Per share
Balance sheet
Liquidity
EPS
$20.01
EPS diluted
$19.8
Free cash flow per share
$21.02
Book value per share
$82.11
Revenue per share
$158.22
TBVPS
$67.08
Total assets
$1.77B
Total liabilities
$533.68M
Debt
$147.91M
Equity
$1.24B
Working capital
$225.66M
Debt to equity
0.12
Current ratio
1.85
Quick ratio
1.64
Net debt/EBITDA
-0.2
Margins
Efficiency
Dividend
EBITDA margin
19.3%
Gross margin
35.7%
Net margin
12.7%
Operating margin
15.3%
Return on assets
17.5%
Return on equity
25.5%
Return on invested capital
64.9%
Return on capital employed
26.4%
Return on sales
16.7%
Dividend yield
0.35%
DPS
$1.8
Payout ratio
9%
CHE stock price
How has the Chemed stock price performed over time
Intraday
0.47%
1 week
-0.97%
1 month
-8.95%
1 year
-12.33%
YTD
-11.1%
QTD
-13.49%
Financial performance
How have Chemed's revenue and profit performed over time
Revenue
$2.38B
Gross profit
$847.8M
Operating income
$364.01M
Net income
$301.73M
Gross margin
35.7%
Net margin
12.7%
The net income has grown by 23% year-on-year
Chemed's operating income has increased by 17% YoY
The net margin is up by 15% year-on-year
CHE's gross profit is up by 10% year-on-year
Growth
What is Chemed's growth rate over time
Valuation
What is Chemed stock price valuation
P/E
25.98
P/B
6.33
P/S
3.29
EV/EBIT
19.41
EV/EBITDA
16.76
EV/Sales
3.24
The EPS has increased by 23% YoY
The price to earnings (P/E) is 16% lower than the last 4 quarters average of 30.9 and 11% lower than the 5-year quarterly average of 29.1
The P/B is 31% less than the 5-year quarterly average of 9.2 and 17% less than the last 4 quarters average of 7.6
Chemed's equity has increased by 21% YoY and by 2.4% from the previous quarter
CHE's P/S is 16% below its last 4 quarters average of 3.9 and 9% below its 5-year quarterly average of 3.6
The revenue rose by 7% year-on-year
Efficiency
How efficient is Chemed business performance
The ROS has increased by 15% YoY
The company's return on invested capital rose by 9% YoY but it fell by 2.3% QoQ
The ROA rose by 6% year-on-year but it has declined by 2.8% since the previous quarter
The ROE has contracted by 4.9% YoY and by 4.1% from the previous quarter
Dividends
What is CHE's dividend history
DPS
$1.8
Dividend yield
0.35%
Payout ratio
9%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Chemed financials performed over time
Chemed's quick ratio has increased by 43% YoY and by 5% from the previous quarter
CHE's current ratio is up by 39% YoY and by 3.9% from the previous quarter
The debt is 88% smaller than the equity
Chemed's equity has increased by 21% YoY and by 2.4% from the previous quarter
CHE's debt to equity is down by 8% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.